Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-929-1 | CAS number: 112-03-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From January 03, 1996 to February 21, 1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Trimethyloctadecylammonium chloride
- EC Number:
- 203-929-1
- EC Name:
- Trimethyloctadecylammonium chloride
- Cas Number:
- 112-03-8
- Molecular formula:
- C21H46NCl
- IUPAC Name:
- N,N,N-trimethylhexadecan-1-aminium chloride
- Test material form:
- other: Light yellowish scales
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Hoe: WISKf (SPF71)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hoechst aktiengesellschaft, Kastengrund, SPF breeding colony
- Age at study initiation: Approximately 7 wk (m) and 8 wk (f)
- Weight at study initiation: Mean: 185g (m) and 171g (f)
- Fasting period before study: Yes
- Housing: In fully air-conditioned rooms in macrolon cages on soft wood granulate in group of 5 animals
- Diet: Ssniff R/M-H (V 1534), ad libitum
- Water: Tap water, ad libitum
- Acclimation period: Atleast one day
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3°C
- Humidity (%): 50 ± 20%
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- Deionized
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 6.3, 8, 12.5 and 20% in deionised water
- Justification for choice of vehicle: Test substance is soluble in water
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Dose range finding study - Doses:
- 800 and 2,000 mg/kg bw for males and 630, 800, 1,250 and 2,000 mg/kg bw
- No. of animals per sex per dose:
- 5 per sex per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14d
- Frequency of observations and weighing: Symptoms and lethality were recorded twice every day, on weekends and public holiday only once. weighing was done weekly
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology - Statistics:
- The LD50 and the equation of the probit line were established in female animals on the basis of the lethality rates by probit analysis.
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- ca. 702.5 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: equivalent to 560.5 mg a.i./kg bw
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 800 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: equivalent to >638 to <1596 mg a.i./kg bw
- Mortality:
- Yes, although in males there was no mortality at 800 mg/kg bw, all animals died at 2,000 mg/kg bw. In females, only 2 and 3 animals survived at 630 and 800 mg/kg bw, respectively. At 1,250 and 2,000 mg/kg bw, all females died.
- Clinical signs:
- other: Decreased spontaneous activity, squatting posture, narrowed palpebrae fissures and irregular respiration. Also, stupor was observed only in the animals of the 2,000 mg/kg bw group. One female animal of the 800 mg/kg bw group showed blood encrusted lid mar
- Gross pathology:
- Macroscopic examination of the dead animals:
Stomach: Full of clear fluid, full of gas, detachment of the mucosa, petechial bleeding
Intestinal tract: Full of yellowish mucous, full of clear fluid, detachment of the mucosa, full of reddish mucosa
The animals killed at the end of the observation period showed macroscopically visible changes.
Applicant's summary and conclusion
- Conclusions:
- Under the study conditions, the LD50 values for the female and male Wistar rats were determined to be 702.5 and >800 to <2000 mg/kg bw, respectively (equivalent to 560.5 and >638 to <1596 mg a.i./kg bw, respectively).
- Executive summary:
A study was conducted to determine the oral acute toxicity of the test substance, C18 TMAC (79.8% active) according to OECD Guideline 401 and EU Method B.1, in compliance with GLP. The experiment was performed in Wistar rats. The test substance was administered as a single dose to 5 female rats per group at 630, 800, 1250 and 2000 mg/kg bw (equivalent to 503, 638, 998 and 1596 mg a.i./kg bw) and to 5 males rats per group at doses of 800 and 2000 mg/kg bw (equivalent to 638 and 1596 mg a.i./kg bw, after which animals were examined for 14 days. Examinations performed were mortality, body weights, clinical signs and gross necropsy for any macroscopic abnormalities. In males, there was no mortality at 800 mg/kg bw, however all animals died at 2000 mg/kg bw. In females, only 2 and 3 animals survived at 630 and 800 mg/kg bw respectively. At 1250 and 2000 mg/kg bw, all females died. Females, therefore, appeared to be more susceptible to the effects of treatment than males. Decreased spontaneous activity, squatting posture, narrowed palpebrae fissures and irregular respiration were recorded. Also, stupor was observed only in the animals of the 2000 mg/kg bw group. One female animal of the 800 mg/kg bw group showed blood encrusted lid margin on Day 6 of the study. All clinical signs were reversible at Day 8 of the study. No effects were seen on the body weight. The animals killed at the end of the observation period showed macroscopically visible changes. Under the study conditions, the LD50 values for the female and male Wistar rats were determined to be 702.5 and >800 to <2000 mg/kg bw, respectively (equivalent to 560.5 and >638 to <1596 mg a.i./kg bw, respectively) (Jensch, 1996).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.